Masashi Kato

16PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersMedical mycologyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 08, 2026
Total Positive Margin Length as a Novel Prognostic Indicator After Radical Prostatectomy.

Takafumi Hibino, Masashi Kato, Toyonori Tsuzuki

|Jun 17, 2025
Risk Model for Lymph Node-Positive Prostate Cancer After Radical Prostatectomy.

Kojiro Tashiro, Keiichiro Mori, Masaki Shiota

|Feb 12, 2025
Prospective observational study on the relationships between genetic alterations and survival in Japanese patients with metastatic castration-sensitive prostate cancer: the impact of IDC-P.

Masashi Kato, Hiroyuki Sato, Yushi Naito

|Mar 01, 2024
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort.

Masashi Kato, Masaki Shiota, Takahiro Kimura

|Sep 20, 2023
Recent insights on the clinical, pathological, and molecular features of intraductal carcinoma of the prostate.

Yushi Naito, Masashi Kato, Jun Nagayama

|Feb 06, 2023
Impact of the coronavirus disease 2019 pandemic on the number of undergoing radical nephroureterectomy and postoperative adjuvant systematic therapy for upper tract urothelial carcinomas in Japan: A multicenter retrospective study.

Katsuhisa Tsuruta, Tsuyoshi Majima, Toshinori Nishikimi

Pageof 3

Frequent Collaborators

5 joint publications

Yoshihisa Matsukawa

5 joint publications

Toyonori Tsuzuki

3 joint publications

Yushi Naito

2 joint publications

Akira Yokomizo